Development Of Carbohydrate Based Self-adjuvanting Vaccine Delivery System
Funder
National Health and Medical Research Council
Funding Amount
$311,647.00
Summary
The world is in a need for effective vaccines for the treatment/prevention of a range of currently occurring diseases. The aim of this project is to develop sugar/lipid-based delivery systems by revolutionary new chemo-enzymatic technology. Expected outcomes of the project will be numerous biologically active vaccine candidates and novel technologies which will lead to effective therapeutic products.